These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36976706)

  • 1. Safety and Efficacy of 68 Ga- or 177 Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases : A Phase 0/I Study.
    Qiu L; Wang Y; Liu H; Wang Q; Chen L; Liu L; Wang L; Feng Y; Chen Y
    Clin Nucl Med; 2023 Jun; 48(6):489-496. PubMed ID: 36976706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and dosimetry of
    Li H; Pei W; Yang X; Qu G; Hua Q; Liu L; Wang Y; Xu T; Chen Y
    EJNMMI Res; 2024 Mar; 14(1):30. PubMed ID: 38517637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Safety and Dosimetry of
    Fernández R; Eppard E; Lehnert W; Jiménez-Franco LD; Soza-Ried C; Ceballos M; Ribbeck J; Kluge A; Rösch F; Meckel M; Zhernosekov K; Kramer V; Amaral H
    J Nucl Med; 2021 Aug; 62(8):1126-1132. PubMed ID: 33419945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results of biodistribution and dosimetric analysis of [
    Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
    Ann Nucl Med; 2019 Jun; 33(6):404-413. PubMed ID: 30877560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lutetium177-Labeled DOTA-Ibandronate: A Novel Radiopharmaceutical for Targeted Treatment of Bone Metastases.
    Wang Q; Yang J; Wang Y; Liu H; Feng Y; Qiu L; Chen Y
    Mol Pharm; 2023 Mar; 20(3):1788-1795. PubMed ID: 36802692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and Internal Dosimetry of 68 Ga-DOTA-IBA PET Imaging for Patients With Bone Metastases.
    Yang J; Deng J; Fan D; Chen G; Lu Z; Liu H; Mok GSP; Chen Y
    Clin Nucl Med; 2023 Oct; 48(10):847-852. PubMed ID: 37418288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [
    Kurth J; Krause BJ; Schwarzenböck SM; Bergner C; Hakenberg OW; Heuschkel M
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):123-135. PubMed ID: 31482426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective comparison of
    Xiang F; Zhang Y; Tan X; Yan Y; Liu H; Ma W; Chen Y
    Front Oncol; 2024; 14():1428498. PubMed ID: 39144828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inferior performance of [
    Has Simsek D; Guzel Y; Denizmen D; Sanli Y; Buyukkaya F; Kovan B; Komek H; Isik EG; Ozkan ZG; Kuyumcu S
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):828-840. PubMed ID: 37947850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [
    Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Bal C
    Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, biological characterization and preliminary human imaging studies of
    Wang Y; Wang Q; Chen Z; Yang J; Liu H; Peng D; Lei L; Liu L; Wang L; Xing N; Qiu L; Feng Y; Chen Y
    Front Oncol; 2022; 12():1027792. PubMed ID: 36591490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy.
    Sainz-Esteban A; Prasad V; Schuchardt C; Zachert C; Carril JM; Baum RP
    Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):501-11. PubMed ID: 22183108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the relative diagnostic performance of
    Deng J; Yang J; Wang Y; Liu G; Chen Y
    Front Oncol; 2024; 14():1364311. PubMed ID: 38585006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 68 Ga-DOTA-Ibandronic Acid PET/CT in a Patient With Chemotherapy-Induced Salivary Gland Hypofunction.
    Liu Y; Ding H; Zhang T; Chen Y; Huang Z
    Clin Nucl Med; 2024 May; 49(5):470-471. PubMed ID: 38465977
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Santos-Cuevas C; Ferro-Flores G; García-Pérez FO; Jiménez-Mancilla N; Ramírez-Nava G; Ocampo-García B; Luna-Gutiérrez M; Azorín-Vega E; Davanzo J; Soldevilla-Gallardo I
    Contrast Media Mol Imaging; 2018; 2018():5247153. PubMed ID: 30534027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-in-human study of dosimetry, safety and efficacy for [
    Zhao R; Lv J; Li M; Xu S; Liang W; Lin X; Gu D; Zeng G; Jin W; Yan Q; Zhong H; Alexoff D; Ploessl K; Zhu L; Kung HF; Wang X
    Eur J Nucl Med Mol Imaging; 2024 Oct; ():. PubMed ID: 39419848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic Agent Targeting Bone Metastasis: A Novel [
    Jin W; Zhao R; Wang R; Choi SR; Ploessl K; Alexoff D; Wu Z; Zhu L; Kung HF
    J Med Chem; 2024 Mar; 67(6):4793-4803. PubMed ID: 38450559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic Neuroendocrine Tumor with Extensive Bone Marrow Involvement at Diagnosis: Evaluation of Response and Hematological Toxicity Profile of PRRT with (177)Lu-DOTATATE.
    Basu S; Ranade R; Thapa P
    World J Nucl Med; 2016; 15(1):38-43. PubMed ID: 26912977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[
    Kamaldeep ; Loharkar S; Das T; Basu S; Banerjee S
    Cancer Biother Radiopharm; 2022 Apr; 37(3):214-225. PubMed ID: 34910891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.